medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2022, Number 4

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2022; 20 (4)

Erythrodermic psoriasis: Case report and literature review

Cabral RGA, García EC, Blanco BEE

Language: Spanish
References: 20
Page: 407-411
PDF size: 213.93 Kb.


ABSTRACT

Erythrodermic psoriasis is the most severe clinical variant of psoriasis and its management represents a challenge due to its high morbidity and mortality. Recognition of this form of psoriasis requires a detailed medical history and an exhaustive evaluation of the patient to establish the diagnosis and rule out other diagnosis. We report a case of a 33-year-old female diagnosed erythrodermic psoriasis as well as, her clinical evolution and histopathological findings.


REFERENCES

  1. Egeberg A, Thyssen JP, Gislason GH y Skov L, Prognosis after hospitalizationfor erythroderma, Acta Derm Venereol 2016; 96(7):959-62. doi:10.2340/00015555-2445.

  2. César A, Cruz M, Mota A y Azevedo F, Erythroderma. A clinical andetiological study of 103 patients, J Dermatol Case Rep 2016; 10(1):1-9.doi: 10.3315/jdcr.2016.1222.

  3. Singh RK, Lee KM, Ucmak D, Brodsky M, Atanelov Z, Farahnik B etal., Erythrodermic psoriasis: pathophysiology and current treatmentperspectives, Psoriasis (Auckland) 2016; 6:93-104. doi: 10.2147/PTT.S101232.

  4. Shao S, Wang G, Maverakis E y Gudjonsson JE, Targeted treatmentfor erythrodermic psoriasis: rationale and recent advances, Drugs2020; 80(6):525-34. doi: 10.1007/s40265-020-01283-2.

  5. Lo Y y Tsai TF, Updates on the treatment of erythrodermic psoriasis,Psoriasis (Auckland) 2021; 11:59-73. doi:10.2147/PTT.S288345.

  6. Madke B, Doshi B, Pande S y Khopkar U, Phenomena in dermatology,Indian J Dermatol Venereol Leprol 2011; 77(3):264-75. doi: 10.4103/0378-6323.79695.

  7. Sullivan JR y Preda VA, Treatments for severe psoriasis, Aust Prescr2009; 32:14-8. doi:10.18773/austprescr.2009.00.

  8. Singh RK, Lee KM, Ucmak D, Brodsky M, Atanelov Z, Farahnik B etal., Erythrodermic psoriasis: pathophysiology and current treatmentperspectives, Psoriasis (Auckland) 2016; 6:93-104. doi:10.2147/PTT.S101232.

  9. Stinco G y Errichetti E, Erythrodermic psoriasis: current and futurerole of biologicals, BioDrugs 2015; 29(2):91-101. doi: 10.1007/s40259-015-0119-4.

  10. Griffiths CE y Barker JN, Pathogenesis and clinical features of psoriasis,Lancet 2007; 370(9583): 263-71. doi: 10.1016/S0140-6736(07)61128-3.

  11. Mistry N, Gupta A, Alavi A y Sibbald RG, A review of the diagnosisand management of erythroderma (generalized red skin), AdvSkin Wound Care 2015; 28(5):228-36; quiz 237-8. doi: 10.1097/01.ASW.0000463573.40637.73.

  12. Rosenbach M, Hsu S, Korman NJ, Lebwohl MG, Young M, BeboBF Jr et al., Treatment of erythrodermic psoriasis: from the medical GÉNESIS ALEJANDRA CABRAL RODRÍGUEZ Y COLS. PSORIASIS ERITRODÉRMIC Aboard of the National Psoriasis Foundation, J Am Acad Dermatol 2010;62(4):655-62. doi: 10.1016/j.jaad.2009.05.048.

  13. Lee WK, Kim GW, Cho HH, Kim WJ, Mun JH, Song M et al., Erythrodermicpsoriasis treated with golimumab: a case report, Ann Dermatol2015; 27(4):446-9. doi:10.5021/ad.2015.27.4.446.

  14. Rao S, Bernshteyn M, Sohal R, Proumen R, Goodman A y ShepherdZ, The management of erythrodermic psoriasis complicatedby cyclosporine, Case Rep Dermatol Med 2020; 2020:5215478. doi:10.1155/2020/5215478.

  15. Teran CG, Teran-Escalera CN y Balderrama C, A severe case of erythrodermicpsoriasis associated with advanced nail and joint manifestations:a case report, J Med Case Rep 2010; 4(1):179. doi: 10.1186/1752-1947-4-179.

  16. Tracey EH, Elston C, Feasel P, Piliang M, Michael M y Vij A, Erythrodermicpresentation of psoriasis in a patient treated with dupilumab, jaadCase Rep 2018; 4(7):708-10. doi: 10.1016/j.jdcr.2018.05.014.

  17. Madhuri G, Kallappa CH y Kumar S, Erythrodermic psoriasis: a casereport, mjps 2019; 5(2):71-3.

  18. Das A, Kumar P y Jain S, Infantile erythrodermic psoriasis: a case reportand review of the literature, Ind J Paediatr Derm 2017; 18(3):248.doi: 10.4103/2319-7250.193026.

  19. Rendo M, Boster J, Dalton SR y Yun H, An uncommon presentationof erythrodermic psoriasis in a patient without a history of psoriasis,Cureus 2019; 11(7):e5099. doi: 10.7759/cureus.5099.

  20. Lu J, Tang S, Yu N, Yi X y Li Y, Successful secukinumab treatmentof erythrodermic psoriasis and psoriatic arthritis concomitant withsevere noninfectious uveitis: a case report, J Int Med Res 2020; 48(11).doi:10.1177/0300060520969494.




2020     |     www.medigraphic.com